Antenatal corticosteroid therapy and late preterm infant morbidity and mortality I.M. Gázquez Serrano, A. Arroyos Plana, O. Díaz Morales, C. Herráiz Perea, A. Holgueras Bragado

Development deficit risks in the late premature newborn: Evaluation at 48 months using the Ages & Stages Questionnaires® X. Demestre, L. Schonhaut, J. Morillas, S. Martínez-Nadal, C. Vila, F. Raspall, P. Sala

Endocrinological outcome in children and adolescents survivors of central nervous system tumours after a 5 year follow-up M. Güemes Hidalgo, M.T. Muñoz Calvo, L. Fuente Blanco, C. Villalba Castaño, G.A. Martos Moreno, J. Argente